Doxorubicin-Induced Cardiotoxicity May Be Alleviated by Bone Marrow Mesenchymal Stem Cell-Derived Exosomal lncRNA via Inhibiting Inflammation

References

• Maejima Y, Adachi S, Ito H, Hirao K, Isobe M. Induction of premature senescence in cardiomyocytes by doxorubicin as a novel mechanism of myocardial damage. Aging Cell. 2008;7(2):125–136. doi:10.1111/j.1474-9726.2007.00358.x
   PubMed Web of Science ®Google Scholar
• Arola OJ, Saraste A, Pulkki K, Kallajoki M, Parvinen M, Voipio-Pulkki LM. Acute doxorubicin cardiotoxicity involves cardiomyocyte apoptosis. Cancer Res. 2000;60(7):1789–1792.
   PubMed Web of Science ®Google Scholar
• Wang Y, Gao W, Shi X, et al. Chemotherapy drugs induce pyroptosis through caspase-3 cleavage of a gasdermin. Nature. 2017;547(7661):99–103. doi:10.1038/nature22393
   PubMed Web of Science ®Google Scholar
• Bartlett JJ, Trivedi PC, Pulinilkunnil T. Autophagic dysregulation in doxorubicin cardiomyopathy. J Mol Cell Cardiol. 2017;104:1–8. doi:10.1016/j.yjmcc.2017.01.007
   PubMed Web of Science ®Google Scholar
• Fang X, Wang H, Han D, et al. Ferroptosis as a target for protection against cardiomyopathy. Proc Natl Acad Sci U S A. 2019;116(7):2672–2680. doi:10.1073/pnas.1821022116
   PubMed Web of Science ®Google Scholar
• Räsänen M, Degerman J, Nissinen TA, et al. VEGF-B gene therapy inhibits doxorubicin-induced cardiotoxicity by endothelial protection. Proc Natl Acad Sci USA. 2016;113(46):13144–13149. doi:10.1073/pnas.1616168113
   PubMed Web of Science ®Google Scholar
• Brown SA, Sandhu N, Herrmann J. Systems biology approaches to adverse drug effects: the example of cardio-oncology. Nat Rev Clin Oncol. 2015;12(12):718–731. doi:10.1038/nrclinonc.2015.168
   PubMed Web of Science ®Google Scholar
• Curigliano G, Cardinale D, Dent S, et al. Cardiotoxicity of anticancer treatments: epidemiology, detection, and management. CA Cancer J Clin. 2016;66(4):309–325. doi:10.3322/caac.21341
   PubMed Web of Science ®Google Scholar
• Gutteridge JM. Lipid peroxidation and possible hydroxyl radical formation stimulated by the self-reduction of a doxorubicin-iron (III) complex. Biochem Pharmacol. 1984;33(11):1725–1728. doi:10.1016/0006-2952(84)90340-X
   PubMed Web of Science ®Google Scholar
• Han X, Zhou Y, Liu W. Precision cardio-oncology: understanding the cardiotoxicity of cancer therapy. NPJ Precis Oncol. 2017;1(1):31. doi:10.1038/s41698-017-0034-x
   PubMed Web of Science ®Google Scholar
• Kalluri R, LeBleu VS. The biology, function, and biomedical applications of exosomes. Science. 2020;367:6478. doi:10.1126/science.aau6977
   Web of Science ®Google Scholar
• Dai J, Su Y, Zhong S, et al. Exosomes: key players in cancer and potential therapeutic strategy. Signal Transduct Target Ther. 2020;5(1):145. doi:10.1038/s41392-020-00261-0
   PubMed Web of Science ®Google Scholar
• Zong T, Yang Y, Lin X, et al. 5’-tiRNA-Cys-GCA regulates VSMC proliferation and phenotypic transition by targeting STAT4 in aortic dissection. Mol Ther Nucleic Acids. 2021;26:295–306. doi:10.1016/j.omtn.2021.07.013
   PubMedGoogle Scholar
• Zou Y, Yang Y, Fu X, et al. The regulatory roles of aminoacyl-tRNA synthetase in cardiovascular disease. Mol Ther Nucleic Acids. 2021;25:372–387. doi:10.1016/j.omtn.2021.06.003
   PubMedGoogle Scholar
• Fu X, He X, Yang Y, et al. Identification of transfer RNA-derived fragments and their potential roles in aortic dissection. Genomics. 2021;113(5):3039–3049. doi:10.1016/j.ygeno.2021.06.039
   PubMed Web of Science ®Google Scholar
• Li X, Yang Y, Wang Z, et al. Targeting non-coding RNAs in unstable atherosclerotic plaques: mechanism, regulation, possibilities, and limitations. Int J Biol Sci. 2021;17(13):3413–3427. doi:10.7150/ijbs.62506
   PubMed Web of Science ®Google Scholar
• Li M, Yang Y, Wang Z, et al. Piwi-interacting RNAs (piRNAs) as potential biomarkers and therapeutic targets for cardiovascular diseases. Angiogenesis. 2021;24(1):19–34. doi:10.1007/s10456-020-09750-w
   PubMed Web of Science ®Google Scholar
• Zhang YF, Xu HM, Yu F, et al. Crosstalk between microRNAs and peroxisome proliferator-activated receptors and their emerging regulatory roles in cardiovascular pathophysiology. PPAR Res. 2018;2018:8530371. doi:10.1155/2018/8530371
   PubMed Web of Science ®Google Scholar
• Li M, Yang Y, Zong J, et al. miR-564: a potential regulator of vascular smooth muscle cells and therapeutic target for aortic dissection. J Mol Cell Cardiol. 2022;170:100–114. doi:10.1016/j.yjmcc.2022.06.003
   PubMed Web of Science ®Google Scholar
• Zhang Y, Jia DD, Zhang YF, et al. The emerging function and clinical significance of circRNAs in thyroid cancer and autoimmune thyroid diseases. Int J Biol Sci. 2021;17(7):1731–1741. doi:10.7150/ijbs.55381
   PubMed Web of Science ®Google Scholar
• Tian C, Yang Y, Bai B, et al. Potential of exosomes as diagnostic biomarkers and therapeutic carriers for doxorubicin-induced cardiotoxicity. Int J Biol Sci. 2021;17(5):1328–1338. doi:10.7150/ijbs.58786
   PubMed Web of Science ®Google Scholar
• Tavakoli Dargani Z, Singla DK. Embryonic stem cell-derived exosomes inhibit doxorubicin-induced TLR4-NLRP3-mediated cell death-pyroptosis. Am J Physiol Heart Circ Physiol. 2019;317(2):H460–h471. doi:10.1152/ajpheart.00056.2019
   PubMed Web of Science ®Google Scholar
• Singla DK, Johnson TA, Tavakoli Dargani Z. Exosome Treatment enhances anti-inflammatory M2 macrophages and reduces inflammation-induced pyroptosis in doxorubicin-induced cardiomyopathy. Cells. 2019;8(10):1224. doi:10.3390/cells8101224
   PubMed Web of Science ®Google Scholar
• Yang Y, Li M, Liu Y, et al. The lncRNA punisher regulates apoptosis and mitochondrial homeostasis of vascular smooth muscle cells via targeting miR-664a-5p and OPA1. Oxid Med Cell Longev. 2022;2022:5477024. doi:10.1155/2022/5477024
   PubMed Web of Science ®Google Scholar
• Ponnusamy M, Liu F, Zhang YH, et al. Long noncoding RNA CPR (Cardiomyocyte Proliferation Regulator) regulates cardiomyocyte proliferation and cardiac repair. Circulation. 2019;139(23):2668–2684. doi:10.1161/CIRCULATIONAHA.118.035832
   PubMed Web of Science ®Google Scholar
• Cai B, Ma W, Ding F, et al. The long noncoding RNA CAREL controls cardiac regeneration. J Am Coll Cardiol. 2018;72(5):534–550. doi:10.1016/j.jacc.2018.04.085
   PubMed Web of Science ®Google Scholar
• Liu N, Kataoka M, Wang Y, et al. LncRNA LncHrt preserves cardiac metabolic homeostasis and heart function by modulating the LKB1-AMPK signaling pathway. Basic Res Cardiol. 2021;116(1):48. doi:10.1007/s00395-021-00887-3
   PubMed Web of Science ®Google Scholar
• Sun L, Zhu W, Zhao P, et al. Long noncoding RNA UCA1 from hypoxia-conditioned hMSC-derived exosomes: a novel molecular target for cardioprotection through miR-873-5p/XIAP axis. Cell Death Dis. 2020;11(8):696. doi:10.1038/s41419-020-02783-5
   PubMed Web of Science ®Google Scholar
• Li KS, Bai Y, Li J, et al. LncRNA HCP5 in hBMSC-derived exosomes alleviates myocardial ischemia reperfusion injury by sponging miR-497 to activate IGF1/PI3K/AKT pathway. Int J Cardiol. 2021;342:72–81. doi:10.1016/j.ijcard.2021.07.042
   PubMed Web of Science ®Google Scholar
• Mao Q, Liang XL, Zhang CL, Pang YH, Lu YX. LncRNA KLF3-AS1 in human mesenchymal stem cell-derived exosomes ameliorates pyroptosis of cardiomyocytes and myocardial infarction through miR-138-5p/Sirt1 axis. Stem Cell Res Ther. 2019;10(1):393. doi:10.1186/s13287-019-1522-4
   PubMed Web of Science ®Google Scholar
• Dubey RK, Gillespie DG, Mi Z, Jackson EK. Exogenous and endogenous adenosine inhibits fetal calf serum-induced growth of rat cardiac fibroblasts: role of A2B receptors. Circulation. 1997;96(8):2656–2666. doi:10.1161/01.CIR.96.8.2656
   PubMed Web of Science ®Google Scholar
• Li RK, Mickle DA, Weisel RD, Zhang J, Mohabeer MK. In vivo survival and function of transplanted rat cardiomyocytes. Circ Res. 1996;78(2):283–288. doi:10.1161/01.RES.78.2.283
   PubMed Web of Science ®Google Scholar
• Zhu J, Liu B, Wang Z, et al. Exosomes from nicotine-stimulated macrophages accelerate atherosclerosis through miR-21-3p/PTEN-mediated VSMC migration and proliferation. Theranostics. 2019;9(23):6901–6919. doi:10.7150/thno.37357
   PubMed Web of Science ®Google Scholar
• Kong L, Zhang Y, Ye ZQ, et al. CPC: assess the protein-coding potential of transcripts using sequence features and support vector machine. Nucleic Acids Res. 2007;35(Web Server issue):W345–349. doi:10.1093/nar/gkm391
   PubMed Web of Science ®Google Scholar
• Sun L, Luo H, Bu D, et al. Utilizing sequence intrinsic composition to classify protein-coding and long non-coding transcripts. Nucleic Acids Res. 2013;41(17):e166. doi:10.1093/nar/gkt646
   PubMed Web of Science ®Google Scholar
• Finn RD, Bateman A, Clements J, et al. Pfam: the protein families database. Nucleic Acids Res. 2014;42(Databaseissue):D222–230. doi:10.1093/nar/gkt1223
   PubMedGoogle Scholar
• Wang L, Park HJ, Dasari S, Wang S, Kocher JP, Cpat: LW. Coding-potential assessment tool using an alignment-free logistic regression model. Nucleic Acids Res. 2013;41(6):e74. doi:10.1093/nar/gkt006
   PubMed Web of Science ®Google Scholar
• Hubisz MJ, Pollard KS, Siepel A. PHAST and RPHAST: phylogenetic analysis with space/time models. Brief Bioinform. 2011;12(1):41–51. doi:10.1093/bib/bbq072
   PubMed Web of Science ®Google Scholar
• Yu G, Wang LG, Han Y, He QY. clusterProfiler: an R package for comparing biological themes among gene clusters. Omics. 2012;16(5):284–287. doi:10.1089/omi.2011.0118
   PubMed Web of Science ®Google Scholar
• Franceschini A, Szklarczyk D, Frankild S, et al. STRING v9.1: protein-protein interaction networks, with increased coverage and integration. Nucleic Acids Res. 2013;41(7):D808–815. doi:10.1093/nar/gks1094
   PubMed Web of Science ®Google Scholar
• Shannon P, Markiel A, Ozier O, et al. Cytoscape: a software environment for integrated models of biomolecular interaction networks. Genome Res. 2003;13(11):2498–2504. doi:10.1101/gr.1239303
   PubMed Web of Science ®Google Scholar
• Gao L, Wang L, Dai T, et al. Tumor-derived exosomes antagonize innate antiviral immunity. Nat Immunol. 2018;19(3):233–245. doi:10.1038/s41590-017-0043-5
   PubMed Web of Science ®Google Scholar
• Trapnell C, Williams BA, Pertea G, et al. Transcript assembly and quantification by RNA-Seq reveals unannotated transcripts and isoform switching during cell differentiation. Nat Biotechnol. 2010;28(5):511–515. doi:10.1038/nbt.1621
   PubMed Web of Science ®Google Scholar
• Jurk D, Wilson C, Passos JF, et al. Chronic inflammation induces telomere dysfunction and accelerates ageing in mice. Nat Commun. 2014;5(1):4172. doi:10.1038/ncomms5172
   Web of Science ®Google Scholar
• Desdín-Micó G, Soto-Heredero G, Aranda JF, et al. T cells with dysfunctional mitochondria induce multimorbidity and premature senescence. Science. 2020;368(6497):1371–1376. doi:10.1126/science.aax0860
   PubMed Web of Science ®Google Scholar
• Pribluda A, Elyada E, Wiener Z, et al. A senescence-inflammatory switch from cancer-inhibitory to cancer-promoting mechanism. Cancer Cell. 2013;24(2):242–256. doi:10.1016/j.ccr.2013.06.005
   PubMed Web of Science ®Google Scholar
• Quagliariello V, De Laurentiis M, Rea D, et al. The SGLT-2 inhibitor empagliflozin improves myocardial strain, reduces cardiac fibrosis and pro-inflammatory cytokines in non-diabetic mice treated with doxorubicin. Cardiovasc Diabetol. 2021;20(1):150. doi:10.1186/s12933-021-01346-y
   PubMed Web of Science ®Google Scholar
• Li X, Yang Y, Wang Z, et al. Multistage-responsive nanocomplexes attenuate ulcerative colitis by improving the accumulation and distribution of oral nucleic acid drugs in the colon. ACS Appl Mater Interfaces. 2022;14(1):2058–2070. doi:10.1021/acsami.1c21595
   PubMed Web of Science ®Google Scholar
• Qi HZ, Yang J, Yu J, et al. Glucose-responsive nanogels efficiently maintain the stability and activity of therapeutic enzymes. Nanotechnol Rev. 2022;11(1):1511–1524. doi:10.1515/ntrev-2022-0095
   Web of Science ®Google Scholar
• Zhao J, Li X, Hu J, et al. Mesenchymal stromal cell-derived exosomes attenuate myocardial ischaemia-reperfusion injury through miR-182-regulated macrophage polarization. Cardiovasc Res. 2019;115(7):1205–1216. doi:10.1093/cvr/cvz040
   PubMed Web of Science ®Google Scholar
• Ni C, Ma P, Wang R, et al. Doxorubicin-induced cardiotoxicity involves IFNγ-mediated metabolic reprogramming in cardiomyocytes. J Pathol. 2019;247(3):320–332. doi:10.1002/path.5192
   PubMed Web of Science ®Google Scholar
• Mu H, Liu H, Zhang J, et al. Ursolic acid prevents doxorubicin-induced cardiac toxicity in mice through eNOS activation and inhibition of eNOS uncoupling. J Cell Mol Med. 2019;23(3):2174–2183. doi:10.1111/jcmm.14130
   PubMed Web of Science ®Google Scholar
• Xia N, Bollinger L, Steinkamp-Fenske K, Förstermann U, Li H. Prunella vulgaris L. Upregulates eNOS expression in human endothelial cells. Am J Chin Med. 2010;38(3):599–611. doi:10.1142/S0192415X10008081
   PubMed Web of Science ®Google Scholar
• Austin KM, Trembley MA, Chandler SF, et al. Molecular mechanisms of arrhythmogenic cardiomyopathy. Nat Rev Cardiol. 2019;16(9):519–537. doi:10.1038/s41569-019-0200-7
   PubMed Web of Science ®Google Scholar
• Buikema JW, Mady AS, Mittal NV, et al. Wnt/β-catenin signaling directs the regional expansion of first and second heart field-derived ventricular cardiomyocytes. Development. 2013;140(20):4165–4176. doi:10.1242/dev.099325
   PubMed Web of Science ®Google Scholar
• Wang J, Liu S, Heallen T, Martin JF. The Hippo pathway in the heart: pivotal roles in development, disease, and regeneration. Nat Rev Cardiol. 2018;15(11):672–684. doi:10.1038/s41569-018-0063-3
   PubMed Web of Science ®Google Scholar
• Lin Z, Zhou P, von Gise A, et al. Pi3kcb links Hippo-YAP and PI3K-AKT signaling pathways to promote cardiomyocyte proliferation and survival. Circ Res. 2015;116(1):35–45. doi:10.1161/CIRCRESAHA.115.304457
   PubMed Web of Science ®Google Scholar
• Dixon SJ, Lemberg KM, Lamprecht MR, et al. Ferroptosis: an iron-dependent form of nonapoptotic cell death. Cell. 2012;149(5):1060–1072. doi:10.1016/j.cell.2012.03.042
   PubMed Web of Science ®Google Scholar
• Stockwell BR, Friedmann Angeli JP, Bayir H, et al. Ferroptosis: a regulated cell death nexus linking metabolism, redox biology, and disease. Cell. 2017;171(2):273–285. doi:10.1016/j.cell.2017.09.021
   PubMed Web of Science ®Google Scholar
• Milano G, Biemmi V, Lazzarini E, et al. Intravenous administration of cardiac progenitor cell-derived exosomes protects against doxorubicin/trastuzumab-induced cardiac toxicity. Cardiovasc Res. 2020;116(2):383–392. doi:10.1093/cvr/cvz108
   PubMed Web of Science ®Google Scholar
• Xia W, Chen H, Xie C, Hou M. Long-noncoding RNA MALAT1 sponges microRNA-92a-3p to inhibit doxorubicin-induced cardiac senescence by targeting ATG4a. Aging. 2020;12(9):8241–8260. doi:10.18632/aging.103136
   PubMedGoogle Scholar